Understanding how the pre-mRNA for immunoglobulin heavy chains is processed is key for understanding how secreted immunoglobulin is made. Processing of immunoglobulin heavy-chain mRNA is also a wellrecognized model for understanding how the splicing and polyadenylation reactions compete in a primary transcript 1 , as it has been estimated that as many as 20% of all human genes may contain competing RNAsplicing and polyadenylation signals 2 . In plasma cells, the secreted form of the immunoglobulin protein is produced by use of the promoterproximal, weak, secretory-specific immunoglobulin poly(A) site in the mRNA. Memory or mature B cell mRNA encodes the membrane-bound B cell antigen receptor, produced by use of the weak nonconsensus 5′ splice site embedded in the secretory-terminal exon and downstream membrane exons, thus resulting in use of the strong promoter-distal heavy-chain membrane poly(A) site. The molecular mechanisms that influence the RNA processing 'choice' have a critical effect on the immune response and expression of secreted immunoglobulin, the main goal of plasma cell development.
Understanding how the pre-mRNA for immunoglobulin heavy chains is processed is key for understanding how secreted immunoglobulin is made. Processing of immunoglobulin heavy-chain mRNA is also a wellrecognized model for understanding how the splicing and polyadenylation reactions compete in a primary transcript 1 , as it has been estimated that as many as 20% of all human genes may contain competing RNAsplicing and polyadenylation signals 2 . In plasma cells, the secreted form of the immunoglobulin protein is produced by use of the promoterproximal, weak, secretory-specific immunoglobulin poly(A) site in the mRNA. Memory or mature B cell mRNA encodes the membrane-bound B cell antigen receptor, produced by use of the weak nonconsensus 5′ splice site embedded in the secretory-terminal exon and downstream membrane exons, thus resulting in use of the strong promoter-distal heavy-chain membrane poly(A) site. The molecular mechanisms that influence the RNA processing 'choice' have a critical effect on the immune response and expression of secreted immunoglobulin, the main goal of plasma cell development.
The transcription start site region of the immunoglobulin heavychain locus (Igh) shows more binding of modified RNA polymerase II (RNAP-II) with phosphorylated Ser2 and Ser5 in its carboxyl-terminal domain (CTD), more loading of the polyadenylation factors CstF and CPSF onto RNAP-II and more binding of ELL2, a transcriptional elongation factor, in plasma cells than in mature B cells; these changes accompany the shift to the use of the promoter-proximal secretory poly(A) site 3 . The binding of ELL2 and CstF-64 to RNAP-II is dependent on phosphorylation of Ser2 on the RNAP-II CTD 3 . No changes occur in the acetylation of histone H3 Lys9 or Lys14 (ref. 3) , consistent with the minimal changes in transcriptional activation of the Igh locus reported before for cell lines representing B cells or plasma cells 4 .
Factors critical for correct processing of immunoglobulin heavychain pre-mRNA are expected to have different expression in plasma cells and may interact directly or indirectly with the Igh locus; ELL2 fulfills these criteria. The ELL ('eleven-nineteen lysine-rich leukemia protein') family of factors acts in vitro in a positive manner to promote elongation by keeping the 3′ OH of nascent RNA in alignment with the catalytic site, thus preventing RNAP-II backtracking [5] [6] [7] [8] . The shift to the secretory-specific form of heavy-chain mRNA in plasma cells is preceded by upregulation of the transcription factors Blimp-1 and IRF4; Blimp-1 targets include the genes encoding ELL2 and its associated factor EAF2 (refs. 9,10) . ELL2 mRNA is also induced by high expression of IRF4 in multiple myeloma, in which IRF4 binds to the ELL2 promoter 11 . It has been demonstrated in several other genes that varying the rate of RNAP-II elongation by mutation or drugs can influence splicing patterns 12 . Cdc73 (also known as parafibromin), a component of the constitutive, multiprotein, polymerase-associated elongation factor, has been shown to facilitate polyadenylation and enhance use of the promoter-proximal poly(A) site 13 .
In this study we establish a mechanistic role for ELL2 in regulating processing of immunoglobulin heavy-chain pre-mRNA. ELL2 was down-modulated in a plasma cell line by transfection with heterogenous ribonucleoprotein F (hnRNP F), a condition that correlates with less production of mRNA encoding the secreted form of immunoglobulin heavy chains 14 . Proteins of 58 kilodaltons (kDa) and 59 kDa arose from the cleavage of full-length 80-kDa ELL2 or from internal initiation of translation at the methionine residue at position 186 (Met186); the abundance of the shorter ELL2 proteins was greater after stimulation with lipopolysaccharide (LPS), a condition that promotes immunoglobulin secretion. ELL2 depletion by specific short hairpin RNA (shRNA) resulted in less association of CstF-64, a polyadenylation factor, with the RNAP-II on the Igh promoter in plasma cells. ELL2 accelerated use of the secretory-specific poly(A) site in Igh both for the γ2b isotype and µ-isotype. In separating RNA processing into its component reactions, we found that both the full-length and smaller ELL2 proteins were able to stimulate promoter-proximal secretory poly(A) site 'choice' and exon skipping. Thus, ELL2 uniquely influences the processing of immunoglobulin heavy-chain pre-mRNA by both enhancing exon skipping of the nonconsensus splice site and facilitating use of the weak promoter-proximal poly(A) site.
RESULTS

Modulation of ELL2 mRNA by transfection of hnRNP F
The binding of hnRNP F to G-rich sequences in pre-mRNA diminishes access of the polyadenylation machinery to a poly(A) site 15 and modulates splicing 16 . The abundance of hnRNP F protein was high in B cells, in which membrane forms of immunoglobulin heavy-chain mRNA predominate, whereas hnRNP F expression was lower in plasma cells, where there is an excess of secretory-specific mRNA 14 (Fig. 1a) . To investigate downstream targets, we did microarray analysis of mRNA expressed in AxJ mouse plasma cells transfected with hnRNP F 14 and in control AxJ cells 17 transfected with a vector lacking hnRNP F, as well as in the A20 mouse B cell line. Of the 207 genes whose expression differed by more than twofold in A20 B cells versus AxJ cells, only three genes had lower expression in both mature B cells and hnRNP F-transfected AxJ cells than in control AxJ cells; therefore, these genes might be important for plasma cell differentiation and immunoglobulin secretion. Those mRNAs encoded ELL2 (Ell2; 103892_r_at), integrin α 4 (Itga4; 102655_at), and retinoblastoma-like p107 (Rbl1; 104476_at; identification numbers for Affymetrix U74Av2 mouse oligonucleotide chip are in parentheses). ELL2 is a transcription elongation factor (map, Fig. 1b) . We confirmed the microarray data for the mRNA by reverse-transcription plus quantitative PCR (quantitative RT-PCR; Table 1 ; primers, Supplementary Table 1) . As determined by the G-rich sequence finder, the three genes modulated by overexpression of hnRNP F in plasma cells contained an unusually large number of potential hnRNP F target sites: Ell2 had 201 G-rich sites, Rbl1 had 432 sites and Itga4 had 127 potential interaction sites. Such high G-rich sequence content was in contrast to that of the 'housekeeping' genes Actb (encoding β-actin), Gapdh (encoding glyceraldehyde phosphate dehydrogenase) and Hprt1 (encoding hypoxanthine phosphoribosyltransferase), for which only a small number of G-rich sites were found. It seems that ELL2 was susceptible to regulation by hnRNP F and was downregulated in B cells, in which expression of hnRNP F is high.
To rule out the possibility of differently expressed, alternatively spliced forms of ELL2, we did RNA-hybridization experiments. We confirmed the size of ELL2 mRNA by RNA blot as a single mRNA of ~4 kilobases (kb) in both A20 and AxJ cells (Fig. 2a, lanes 3,4 and 7, 8 ). PC4 is a transcription factor that also has higher expression in plasma cells (Fig. 2a, lanes 1,2,5,6 ). We used GAPDH mRNA as a size control (Fig. 2a, lanes 5-8) . We confirmed that result by applying a systematic PCR approach with overlapping sets of primers. The observed PCR products showed no evidence of other mRNA species in either A20 or AxJ cells (data not shown).
ELL2 protein expression
To examine ELL2 protein expression in mature B cells and plasma cells, we generated antibodies that recognize ELL2. We generated rabbit antibody R4213 to peptides corresponding to internal amino acids of ELL2 (Fig. 1b) . R4213 reacted with protein made from a transfected full-length ELL2 cDNA clone identified by a cloned epitope tag ( Supplementary  Fig. 1 ). When we probed immunoblots with R4213, almost no full-length ELL2 protein was detectable in cells or nuclei; however, expression of a 58-to 59-kDa protein doublet was much more abundant in AxJ plasma cells than in A20 B cells (Fig. 2b, lanes 1,2, and Supplementary Fig. 1 ). Antibody R4502, to a different ELL2 epitope (Fig. 1b) that has been described before 3 , detected a pattern of protein expression similar to that seen with R4213. Immunoblot analysis of ELL2 protein expression in mouse mature B cells and plasma cells with monoclonal antibody 83104, which recognizes the NH 2 -terminal end of ELL2 produced by bacteria 7 , showed no change in expression of the predicted full-length ELL2 protein species (Fig. 2b, lanes 3,4; longer exposure, lanes 5,6). Full-length ELL2 protein therefore must be in low abundance or turn over rapidly or both. The more rapidly migrating proteins recognized by the secondary antibody in the immunoblots were the immunoglobulin heavy-chain membrane form, which served as a loading control, and the immunoglobulin heavy-chain secretory form; the greater abundance of the secretory form confirmed that the AxJ cells act like plasma cells. 
A r t i c l e s
In addition, the 58-to 59-kDa form of ELL2, but not the 80-kDa form, was greater in abundance in mouse splenic B cells that had undergone 72 h of stimulation with LPS in vitro (Fig. 2c) , a time at which Blimp-1, immunoglobulin secretion and immunoglobulin light chain (Fig. 2c , right lane) were induced. We confirmed that the 58-to 59-kDa band was indeed ELL2 protein by in vitro translation of the cDNA ( Supplementary  Fig. 2 ) and by use of shRNA specific for ELL2 (iell2), which diminished expression of the 58-to 59-kDa protein (Fig. 2d , right lane). Results obtained with untreated cells and those treated with nonspecific shRNA (iNS) were identical (data not shown).
Examination of the predicted ELL2 protein sequence in several species (Supplementary Table 2 ) identified many evolutionarily conserved AUG (methionine) codons at which translation might initiate, as well as regions where there might be cleavage of the protein at conserved Arg-Lys sequences by stress-induced proteases 18 . Through a series of in vitro transcription-translation and site-directed mutagenesis experiments ( Supplementary Fig. 2 ), we found that the shorter forms of ELL2 protein arose both from post-translational processing (59 kDa), most probably from the multiple tryptic cleavage sites near Met186, and from initiation of protein synthesis at Met186 (the 58-kDa form). The amino acid conservation in this region across many species indicates a potentially important role for these two processes in ELL2 function.
ELL2 functionally associates with Igh
The Igh promoter has more ELL2 and polyadenylation factors, including CstF-64, associated with RNAP-II in AxJ plasma cells than in A20 B cells 3 , which indicates B cell stage-specific differences in the ability to process mRNA. This association with polymerase was inhibited by 5,6-dichlorobenzimidazole, an adenosine analog that inhibits the addition of Ser2 to the CTD of RNAP-II; the observed linkages with the polymerase are therefore dependent on the phosphorylation state of the CTD 3 . The cleavage-stimulation factor CstF-64 recognizes a GU-or U-rich site ~50 nucleotides downstream of the sequence AAUAAA and induces cutting of the pre-mRNA, one of the final steps before the addition of 3′ poly(A). To determine if ELL2, CstF-64 and RNAP-II associated in splenic B cells, we did chromatin immunoprecipitation (ChIP) before and after 72 h of stimulation with LPS, a condition in which B cells are activated and secretory immunoglobulin mRNA production is induced. The many variable heavy-chain regions expressed in splenic B cells precluded determination of the protein-protein linkages at the promoter, but it was clear that after LPS treatment, RNAP-II, ELL2 and CstF-64 associated with the Igh µ-gene segment across its length from joining region 4 onward ( Fig. 3a) and that the amount of ELL2 relative to CstF-64 did not vary much, even 3′ of the secretory poly(A) site.
Assessing the association of RNAP-II with ELL2 and CstF-64 across an IgG2b reporter gene construct in the mouse plasma cell line J558L would determine the extent of retention of these factors relative to the promoter. J558L cells lack an endogenous Igh gene but process the mRNA from a transfected IgG2b gene construct driven by the Igh promoter in a plasma cell-specific way 19 ; expression of plasma cell markers such as ELL2, Blimp-1 and Xbp-1 is high in these cells. ChIP experiments with untransfected J558L and the Igh probes used for quantitative PCR 3 showed no signal greater than background (data not shown). We determined the profiles of the RNAP-II, ELL2 and CstF-64 immunoprecipitated across this transfected IgG2b heavychain gene segment (Fig. 3b) . The ratio of factors was relatively constant across the gene, with lower abundance of all factors at the internal heavy-chain enhancer, a site at which the polymerase may travel faster or be less accessible to immunoprecipitation, and a slight 'fall-off ' at the region after the 3′-most poly(A) site.
ELL2 and CstF-64 are both associated with the phosphorylated form of the RNAP-II CTD 3 . If ELL2 were necessary for binding of CstF-64 to RNAP-II, then removal of ELL2 should result in less CstF-64 binding. Indeed, J558L cells transfected with the IgG2b reporter plus a plasmid encoding ELL2-specific shRNA (iell2) had less ELL2 as well as less CstF-64 bound to the TATA transcription start-site region than did cells transfected with reporter only or reporter plus nonspecific shRNA (iNS; Fig. 4) . The re-addition of either wild-type lgH mb A20 AxJ A20 AxJ A20 AxJ ELL2 (with a hemagglutinin tag) or COOH ELL2 (encoding the 58-kDa ELL2 protein with a short amino-terminal sequence tag; Fig. 1b ) restored the binding of both factors to RNAP-II. We conclude that ELL2 facilitates recruitment of the polyadenylation factor CstF-64 to the RNAP-II near the Igh promoter. This binding is expected to favor the use of promoter-proximal poly(A) sites, leading to more production of the secretory-specific form of immunoglobulin heavychain in plasma cells than in B cells, because the polymerase is poised to deliver the polyadenylation factors to the nascent RNA. Only a small fraction of the J558L cells became transfected with the reporter and shRNA, so the endogenous genes Actb and Gapdh in the surrounding cells served as controls for equal immunoprecipitation with the various antibodies (Supplementary Fig. 3) . In those experiments, the Actb and Gapdh promoters were also associated with ELL2 and CstF-64 but to a lesser extent than was the Igh promoter.
ELL2 influences Igh precursor mRNA processing 'choice'
To determine if ELL2 influences immunoglobulin heavy-chain mRNA processing, we did a series of transient cotransfection experiments in the B cell line A20, in which ELL2 expression is normally low, using the same IgG2b reporter construct as in the ChIP experiments (described above) together with cDNA encoding ELL2 and other factors (ELL2 clones, Fig. 1b) . After 48 h, we quantified the secretory and membrane IgG2b species produced in the transfected cells by quantitative RT-PCR. We determined equal efficiency of transfection by the ELL2 derivatives, CstF-64 and PC4 plasmids by quantitative RT-PCR of their mRNA with primers unique for the transfected products (data not shown).
Setting the ratio of secretory mRNA/membrane mRNA produced from the IgG2b reporter plus empty vector in the B cells as 1, we found an enhancement in the production of secretory-specific mRNA of approximately 4.8-fold in A20 cells transfected with wild-type ELL2 (able to produce the 80-, 59-and 58-kDa forms; Fig. 5a ). In cells transfected with an ELL2 plasmid carrying a Met(133,138,186)Ile substitution (able to produce the 80-and 59-kDa forms), the production of IgG2b secretory mRNA from the reporter was still stimulated about 3.3-fold greater than that of cells transfected with empty vector, almost as high as that in cells transfected with cDNA for wild-type ELL2. On the basis of these observations, we conclude that ELL2 has a positive effect on influencing the processing of Igh products toward immunoglobulin secretion.
No significant stimulation of the secretory form over the membrane form was achieved with either NH 2 ELL2 (amino acids 1-285 of ELL2) or COOH ELL2. The result with COOH ELL2 was unexpected, given its ability to restore the association of CstF-64 with RNAP-II (Fig. 4) with the same reporter with the Igh promoter. It is conceivable that the NH 2 terminal epitope tag on COOH ELL2 may have interfered with its action or that the missing portion may be important in the context of the totality of processing reactions. A plasmid encoding shRNA specific for the 3′ end of endogenous mouse ELL2 mRNA (iell2) resulted in a decrease in the secretory/membrane ratio of mRNA produced from the Igh reporter (Fig. 5a) . A nonspecific shRNA construct (iNS) with no complementarity to or effect on ELL2 expression was ineffective in changing the secretory-to-membrane poly(A) mRNA 'choice'. The re-addition of plasmid encoding wildtype ELL2 restored the production of secretory immunoglobulin heavy-chain mRNA to a significant extent. This is further support for the idea that ELL2 is involved in influencing the processing of immunoglobulin heavy-chain mRNA.
The stimulation of secretory mRNA with ELL2 described above was more efficient than cotransfection with CstF-64 alone (Fig. 5a) . A dominant negative mutant of CstF-64 lacking the final 282 amino acids at the COOH domain that are essential for CstF-64 function 20, 21 suppressed secretory poly(A) site use to about 12% that of empty vector. We found no enhancement of secretory-specific mRNA production after transfection with PC4, a factor reported to have many transcriptionstimulatory activities, including binding CstF-64 (refs. 22,23) . Fig. 1a) . VDJ, variable-diversity-joining; sec+200, primer set beginning 200 nucleotides past the secretory poly(A) site. *P < 0.05 (analysis of variance (ANOVA)). Data are representative of three to six experiments (error bars, s.e.m.). (Fig. 1a) and either left untreated (None) or incubated for 24 h with nonspecific shRNA (iNS) or with ELL2-specific shRNA alone (iell2) or together with an intact wild-type ELL2 clone (iell2 + WT ELL2) or the ELL2 clone starting at Met186 (iell2+ COOH ELL2), precipitated with antibody to RNAP II, ELL2 or CstF-64 or normal rabbit serum; the resulting sheared DNA was uncrosslinked and amplified by real-time quantitative PCR with primers for the 5′ end of the IgG2b gene (TATA). *P ≤ 0.01 (nonparametric analysis of variance). Data are representative of three to six experiments (error bars, s.e.m.). 
A r t i c l e s
To confirm that ELL2 stimulates secretory-specific poly(A) site use in the Igh locus in primary cells, we isolated mouse splenic B cells, incubated them with LPS for 24 h and then transfected them with plasmids encoding shRNA (iNS or iell2, as described above) or mock transfected them. We transfected all cells with plasmid carrying a green fluorescent protein marker. Then, 24 h later (48 h total), we collected cells positive for green fluorescent protein. HPRT expression, shown before to remain unchanged after B cell terminal differentiation, served as the baseline for quantitative RT-PCR 24 . Endogenous expression of ELL2 rose from initially ~30% that of HPRT in unstimulated B cells to ~2.3-fold higher than HPRT in LPS-stimulated cells, an increase of approximately sevenfold, a difference equivalent to that in the AxJ plasma cells (Table 1 and Figs. 2c and 5b) . In the absence of shRNA, the secretory/membrane ratio rose in parallel after LPS treatment from approximately 0.5:1 to 5.5:1. In splenic B cells treated for 24 h with LPS and nonspecific shRNA, there was no change in the ELL2 amount or the secretory/membrane ratio relative to that of untreated cells. In splenic B cells treated with LPS and ELL2-specific shRNA (iell2), the abundance of ELL2 mRNA was lower than that of untreated cells or cells treated with nonspecific shRNA (iNS), and the secretory/membrane ratio was significantly lower (Fig. 5b) . Therefore, diminishing the amount of ELL2 mRNA decreased processing of the endogenous Igh µ-pre-mRNA to the secretory form in these cells, which confirmed its involvement in immunoglobulin heavy-chain expression in primary cells.
ELL2 and tandem poly(A) site selection
ELL2 protein increases the production of secretory mRNA; this could be achieved either by enhancement in the use of the promoterproximal poly(A) site or an increase in exon skipping of the splice site in constant heavy-chain region-3 (C H 3; γ) or C H 4 (µ) or both. Some elongation factors have been shown to influence one or the other but not both reactions on nonlymphoid genes. To explicitly address the mechanism(s) altered by ELL2, we separated the reaction into its two components. To assess polyadenylation enhancement of ELL2, we modified a reporter plasmid driven by the Igh enhancer and an SV40 promoter with plasma cell-specific expression 25 . We used the SV40 promoter-driven plasmids to confirm the parameters of the immunoglobulin heavy-chain secretory-versus-membrane poly(A) 'choice' in published studies 26 . The secretory Igh γ-poly(A) site was in competition with a downstream SV40 early poly(A) site (Fig. 6a) . The Igh γ-derived intervening sequence DNA between the sites is ~2 kb in length, in contrast to the 3 kb between the secretory and membrane poly(A) sites in the Igh genes. The addition of wild-type ELL2 resulted in a 2.8-fold stimulation in the use of the promoter-proximal poly(A) site (Fig. 6b) . The addition of NH 2 ELL2 showed no significant change in use of the promoter-proximal, secretory poly(A) site, whereas COOH ELL2 (encoding the 58-kDa form of the protein) stimulated use of the secretory poly(A) site, consistent with its ability to facilitate the attachment of CstF-64 to the RNAP-II complex, as shown before (Fig. 4) . The addition of ELL2-specific shRNA (iell2) resulted in less use of the secretory poly(A) site; the readdition of full-length ELL2 restored use of the secretory poly(A) site. 
These results are consistent with enhancement in use of the promoterproximal, secretory-specific poly(A) site by ELL2.
Effect of ELL2 on splicing of alternative exons
We assayed whether the recombinant ELL2 proteins could also influence splice-site 'choices' . Studies with a fibronectin gene containing an alternatively spliced extra domain (ED1 exon) [27] [28] [29] have shown that more efficient elongation of RNAP-II leads to more exon skipping, whereas slowing the polymerase leads to more exon inclusion. Using the ED1 alternative splicing construct 12 as a reporter in Hep3B human liver cells (Fig. 7a) , we found more skipping of the ED1 exon with reporters driven by the HBA1 (human α-globin) promoter plus wild-type ELL2 lacking the hemagglutinin tag, but not with reporters driven by the Fn1 (fibronectin) promoter or cytomegalovirus promoter (Fig. 7b) . These results are consistent with published studies and confirm that ELL2 acts to enhance exon skipping with some promoters. In A20 B cells, using the ED1 reporter driven by the Igh promoter and enhancer, we found approximately threefold more exon skipping after the addition of full-length wild-type ELL2, relative to that of cells transfected with empty vector (Fig. 7c) . The Met(133,138,186)Ile form of ELL2 caused an increase of approximately twofold in skipping, as did the COOH ELL2 (58-kDa protein). NH 2 ELL2 was ineffective in changing the splicing pattern. We conclude that higher expression of wild-type full-length ELL2or COOH ELL2 facilitates significant exon skipping; this could shift the balance toward use of the secretory poly(A) site in the Igh transcription unit, which would otherwise be removed by the use of the 5′ splice-site encased in the final secretory exon to membrane exon 1 (M1). Given these results, together with the stimulation of promoter-proximal poly(A) site use and enhanced loading of CstF-64 onto RNAP-II, we conclude that the elongation factor ELL2 influences the processing of immunoglobulin heavy-chain pre-mRNA by influencing both exon skipping (splicing) and polyadenylation ( Supplementary Fig. 4 ).
DISCUSSION
Here we have established the transcription elongation factor ELL2 as an essential regulator of the switch in immunoglobulin heavy-chain mRNA from the membrane-bound form to the secreted form, a fundamental step in plasma cell differentiation. ELL2 influenced the processing of heavy-chain pre-mRNA, shifting it away from splicing to M1 and toward use of the secretory-specific poly(A) site. The ELL2 protein accumulated mainly as a shortened form (58-59 kDa), and clones encoding either the full-length form (80 kDa) or the shortened form were able to direct the binding of CstF-64 to the RNAP-II near the Igh promoter. The addition of the full-length ELL2 clone altered heavychain processing in a B cell line, whereas clones encoding the short and long forms of ELL2 drove use of the promoter-proximal poly(A) site and alternative splicing in model systems, recapitulating the two competing processing events that occur in the Igh locus.
ELL2 expression was down-modulated after transfection of plasma cells with hnRNP F, a condition shown before to skew the processing of immunoglobulin heavy-chain mRNA by binding to the secretory poly(A) site 14 . Here, results from our microarray data and quantitative RT-PCR experiments suggested that hnRNP F also suppressed ELL2 expression, most probably by binding to the multiple G-rich sequences in the Ell2 sequence, resulting in even less of the polyadenylation versus splicing reaction. Determining the ratio of secretory to membrane-specific heavy-chain mRNA is complex and is influenced at least in part by the diminished abundance in plasma cells of several previously described trans-acting factors, U1A, hnRNP F and some serine-arginine-rich proteins 14, 30, 31 . Overexpression of the polyadenylation-cleavage factor CstF-64 has been shown to influence the heavy-chain RNA processing 'choice' in chicken DT40 cells 32 . Although transfection of plasma cells with hnRNP F resulted in lower ELL2 expression and immunoglobulin secretion, it did not influence the abundance of CstF-64, U1A or the serine-arginine-rich proteins (as shown by our microarray data).
We have incorporated our findings into a model of the present knowledge of immunoglobulin heavy-chain mRNA processing. ELL2 serves a key role by directing the association of CstF-64 with RNAP-II in plasma cells. ChIP experiments with plasma cells have shown that the polyadenylation factors and ELL2 are associated with Igh more efficiently in plasma cells than in B cells, probably because of the greater phosphorylation of the RNAP-II CTD 3 . Here we have shown, by inhibiting ELL2 expression with shRNA, that binding of CstF-64 to RNAP-II depended on ELL2. As a consequence of loading onto RNAP-II, the polyadenylation factors were present at a high local concentration and acted on the weak secretory-specific poly(A) site to direct its recognition and cleavage. We hypothesize that ELL2 prevents recognition of the weak alternative splice site in the C H 3 exon (γ-gene; or C H 4 in µ-gene) used to produce the membrane-specific form of the heavy chain. Indeed, factors that speed the RNAP-II elongation rate are known to aid exon skipping 12 . As splice-site and poly(A)-site use are in direct competition 33 , the secretory-specific poly(A) site is acted on by the polyadenylation factors loaded on RNAP-II when ELL2 abundance is higher. The balance tips toward promoter-proximal polyadenylation and thus to immunoglobulin secretion. Use of the promoter-proximal poly(A) site is stimulated by at least one other elongation factor, Cdc73, whose expression is constitutive in nonlymphoid cells 13 . ELL2 is unique among transcription elongation factors thus far described in influencing exon skipping, enhancing promoter proximal poly(A) site 'choice' and demonstrating developmental regulation.
CstF-64 was associated with the Igh µ-and γ-gene segments along their entire lengths, which indicates that the polyadenylation complex remains bound to the RNAP-II even as it processes the mRNA and beyond. The polyadenylation factors may remain tightly associated with the polymerase to act at the downstream membrane poly(A) site should the first poly(A) site fail to cause processing. This linkage may occur because the subunits of the polyadenylation complex involved in the RNA binding are different from those involved in polymerase association. For example, CstF-64 binds GU regions in RNA but is found in a trimeric complex with CstF-50 and CstF-77; however, it is CstF-50 that binds to RNAP-II (refs. 34,35) . Additionally, the CstF trimer is found associated with many other poly(A) site-processing factors in a large complex of 85 different proteins. Neither ELL1 nor ELL2 has been found in this large preformed complex 35 , so if ELL2 and CstF-64 associate directly, this association is only transient, whereas their main interaction is clearly through the phosphorylated CTD of RNAP-II, on the basis of published studies 3 . It is also clear that at least 400 nucleotides of RNA must extrude from mammalian RNAP-II before processing takes place 36 . In yeast, for at least some genes, polyadenylation factors add onto the polymerase as it transits close to the 3′ end. In human cells there is growing evidence that polyadenylation factors may add to the RNAP-II complex much nearer the promoter in some but not all genes 13, 37, 38 . Our observation that Ser2 phosphorylation of the CTD of RNAP-II occurs at or near the promoter in the Igh γ-gene segment rather than near the 3′ end, as in yeast genes 3 , indicates fundamental differences from yeast that facilitate the association of ELL2 and CstF-64 with RNAP-II. Promoters and elements in genes are known to direct alternative splicing; it has been suggested that they might do this by directing the association of specific elongation and RNA-processing factor combinations and concentrations specific to the gene 39 . We have shown that ELL2 strongly binds and influences the Igh promoter, but other promoters are influenced as well; the SV40-driven reporter plasmid showed more proximal poly(A) site 'choice' with the addition of ELL2, whereas exon skipping was enhanced by ELL2 with the Igh promoterand HBA1 promoter-driven reporters but not with the cytomegalovirus promoter-driven reporter. There was also an association of ELL2 and CstF-64 with 'housekeeping' genes such as Actb and Gapdh. Thus, ELL2 may have more generalized effects beyond immunoglobulin secretion and may regulate other genes; exploring other targets of ELL2 should prove informative for plasma cell biology.
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